Intraperitoneally administrated insulin reaches maximum circulating insulin levels faster and decreases faster than after subcutaneous insulin delivery.3 4 Intraperitoneal insulin administration also seems to decrease the risk of hypoglycemia.5 This evidence concerns the gene INS and Hypoglycemia.